Availability of COVID vaccine for kids will pave way for school reopening, says AIIMS chief

The AIIMS stressed that though children mostly have mild infections of COVID-19 and some even are asymptomatic, they can be carriers of the infection.

Making COVID-19 vaccine available for children will be a milestone achievement and pave the way for reopening of schools and resumption of outdoor activities for them, AIIMS Chief Dr Randeep Guleria has said. He said the data of phase two and three trial of Bharat Biotech’s Covaxin on two to 18 years age group is expected by September. The vaccine can be available for children in India around that time following approval from the drug regulator, he said. “If the Pfizer vaccine gets approval before that, then it can also be an option for children,” Dr Guleria told PTI on Saturday.